| Characteristic | Overall N = 2,9321 |
D1 N = 1,7451 |
D2 N = 6191 |
D3 N = 5681 |
p-value2 |
|---|---|---|---|---|---|
| All-cause mortality (30-day) | 76 (2.6%) | 36 (2.1%) | 26 (4.2%) | 14 (2.5%) | 0.020 |
| All-cause mortality (1-year) | 171 (5.8%) | 88 (5.0%) | 54 (8.7%) | 29 (5.1%) | 0.004 |
| Ischemic stroke (30-day) | 12 (0.4%) | 6 (0.3%) | 4 (0.6%) | 2 (0.4%) | 0.516 |
| Ischemic stroke (1-year) | 14 (0.5%) | 11 (0.6%) | 2 (0.3%) | 1 (0.2%) | 0.454 |
| Myocardial infarction (30-day) | 12 (0.4%) | 3 (0.2%) | 8 (1.3%) | 1 (0.2%) | 0.002 |
| Myocardial infarction (1-year) | 22 (0.8%) | 10 (0.6%) | 5 (0.8%) | 7 (1.2%) | 0.243 |
| Permanent pacemaker (30-day) | 47 (1.6%) | 27 (1.5%) | 9 (1.5%) | 11 (1.9%) | 0.770 |
| Permanent pacemaker (1-year) | 47 (1.6%) | 27 (1.5%) | 9 (1.5%) | 11 (1.9%) | 0.770 |
| Annular rupture | 1 (<0.1%) | 0 (0%) | 1 (0.2%) | 0 (0%) | 0.405 |
| Paravalvular AR (grade) | 0.624 | ||||
| None | 2,489 (89%) | 1,484 (88%) | 514 (88%) | 491 (90%) | |
| Trace/Mild | 303 (11%) | 185 (11%) | 66 (11%) | 52 (9.6%) | |
| Moderate | 14 (0.5%) | 8 (0.5%) | 5 (0.9%) | 1 (0.2%) | |
| Severe | 1 (<0.1%) | 1 (<0.1%) | 0 (0%) | 0 (0%) | |
| Length of stay (days) | 2.00 (1.00–3.00) | 1.00 (1.00–3.00) | 2.00 (1.00–4.00) | 2.00 (1.00–3.00) | <0.001 |
| 1 n (%); Median (Q1–Q3) | |||||
| 2 Fisher’s exact test; Kruskal-Wallis rank sum test | |||||